Maqola

Reprogramming Tumor-Associated Macrophages To Reverse EGFR<sup>T790M</sup> Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat

Huige PengUniversity of Chinese Academy of Sciences, Beijing 100049, ChinaBinfan ChenUniversity of Chinese Academy of Sciences, Beijing 100049, ChinaWei HuangShanghai Institute of Materia MedicaYubo TangShanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYifan JiangShanghai Institute of Materia MedicaWenyuan ZhangUniversity of Chinese Academy of SciencesYongzhuo HuangShanghai Institute of Materia Medica

2017en

Ochiq kirish: yoʻq

ABI

Annotatsiya

-caused resistance to tyrosine kinase inhibitor treatment.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.1021/acs.nanolett.7b03756

Iqtiboslar va manbalar

3 ta iqtibos0 ta foydalanilgan manba